5-hydroxytryptamine receptor 1A
Details
- Name
- 5-hydroxytryptamine receptor 1A
- Synonyms
- 5-HT-1A
- ADRB2RL1
- ADRBRL1
- G-21
- Serotonin receptor 1A
- Gene Name
- HTR1A
- Organism
- Humans
- Amino acid sequence
>lcl|BSEQ0018934|5-hydroxytryptamine receptor 1A MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAA IALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCC TSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPED RSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADT RHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGN SKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLP FFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFC RQ
- Number of residues
- 422
- Molecular Weight
- 46106.335
- Theoretical pI
- 9.05
- GO Classification
- Functionsserotonin receptor activityProcessesadenylate cyclase-inhibiting serotonin receptor signaling pathway / behavioral fear response / cell proliferation / exploration behavior / G-protein coupled receptor signaling pathway / positive regulation of cell proliferation / regulation of behavior / regulation of dopamine metabolic process / regulation of hormone secretion / regulation of serotonin secretion / serotonin metabolic process / serotonin receptor signaling pathway / vasoconstrictionComponentsintegral component of plasma membrane / plasma membrane
- General Function
- Serotonin receptor activity
- Specific Function
- G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Beta-arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. Signaling inhibits adenylate cyclase activity and activates a phosphatidylinositol-calcium second messenger system that regulates the release of Ca(2+) ions from intracellular stores. Plays a role in the regulation of 5-hydroxytryptamine release and in the regulation of dopamine and 5-hydroxytryptamine metabolism. Plays a role in the regulation of dopamine and 5-hydroxytryptamine levels in the brain, and thereby affects neural activity, mood and behavior. Plays a role in the response to anxiogenic stimuli.
- Pfam Domain Function
- 7tm_1 (PF00001)
- Transmembrane Regions
- 37-62 74-98 111-132 153-178 192-217 346-367 379-403
- Cellular Location
- Cell membrane
- Gene sequence
>lcl|BSEQ0018935|5-hydroxytryptamine receptor 1A (HTR1A) ATGGATGTGCTCAGCCCTGGTCAGGGCAACAACACCACATCACCACCGGCTCCCTTTGAG ACCGGCGGCAACACTACTGGTATCTCCGACGTGACCGTCAGCTACCAAGTGATCACCTCT CTGCTGCTGGGCACGCTCATCTTCTGCGCGGTGCTGGGCAATGCGTGCGTGGTGGCTGCC ATCGCCTTGGAGCGCTCCCTGCAGAACGTGGCCAATTATCTTATTGGCTCTTTGGCGGTC ACCGACCTCATGGTGTCGGTGTTGGTGCTGCCCATGGCCGCGCTGTATCAGGTGCTCAAC AAGTGGACACTGGGCCAGGTAACCTGCGACCTGTTCATCGCCCTCGACGTGCTGTGCTGC ACCTCATCCATCTTGCACCTGTGCGCCATCGCGCTGGACAGGTACTGGGCCATCACGGAC CCCATCGACTACGTGAACAAGAGGACGCCCCGGCGCGCCGCTGCGCTCATCTCGCTCACT TGGCTTATTGGCTTCCTCATCTCTATCCCGCCCATGCTGGGCTGGCGCACCCCGGAAGAC CGCTCGGACCCCGACGCATGCACCATTAGCAAGGATCATGGCTACACTATCTATTCCACC TTTGGAGCTTTCTACATCCCGCTGCTGCTCATGCTGGTTCTCTATGGGCGCATATTCCGA GCTGCGCGCTTCCGCATCCGCAAGACGGTCAAAAAGGTGGAGAAGACCGGAGCGGACACC CGCCATGGAGCATCTCCCGCCCCGCAGCCCAAGAAGAGTGTGAATGGAGAGTCGGGGAGC AGGAACTGGAGGCTGGGCGTGGAGAGCAAGGCTGGGGGTGCTCTGTGCGCCAATGGCGCG GTGAGGCAAGGTGACGATGGCGCCGCCCTGGAGGTGATCGAGGTGCACCGAGTGGGCAAC TCCAAAGAGCACTTGCCTCTGCCCAGCGAGGCTGGTCCTACCCCTTGTGCCCCCGCCTCT TTCGAGAGGAAAAATGAGCGCAACGCCGAGGCGAAGCGCAAGATGGCCCTGGCCCGAGAG AGGAAGACAGTGAAGACGCTGGGCATCATCATGGGCACCTTCATCCTCTGCTGGCTGCCC TTCTTCATCGTGGCTCTTGTTCTGCCCTTCTGCGAGAGCAGCTGCCACATGCCCACCCTG TTGGGCGCCATAATCAATTGGCTGGGCTACTCCAACTCTCTGCTTAACCCCGTCATTTAC GCATACTTCAACAAGGACTTTCAAAACGCGTTTAAGAAGATCATTAAGTGTAAGTTCTGC CGCCAGTGA
- Chromosome Location
- 5
- Locus
- 5q11.2-q13
- External Identifiers
Resource Link UniProtKB ID P08908 UniProtKB Entry Name 5HT1A_HUMAN GenBank Protein ID 189928 GenBank Gene ID M28269 GenAtlas ID HTR1A HGNC ID HGNC:5286 - General References
- Kobilka BK, Frielle T, Collins S, Yang-Feng T, Kobilka TS, Francke U, Lefkowitz RJ, Caron MG: An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature. 1987 Sep 3-9;329(6134):75-9. [Article]
- Kitano T, Liu YH, Ueda S, Saitou N: Human-specific amino acid changes found in 103 protein-coding genes. Mol Biol Evol. 2004 May;21(5):936-44. Epub 2004 Mar 10. [Article]
- Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article]
- Parks CL, Chang LS, Shenk T: A polymerase chain reaction mediated by a single primer: cloning of genomic sequences adjacent to a serotonin receptor protein coding region. Nucleic Acids Res. 1991 Dec;19(25):7155-60. [Article]
- Aune TM, McGrath KM, Sarr T, Bombara MP, Kelley KA: Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine. J Immunol. 1993 Aug 1;151(3):1175-83. [Article]
- Fargin A, Raymond JR, Lohse MJ, Kobilka BK, Caron MG, Lefkowitz RJ: The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature. 1988 Sep 22;335(6188):358-60. [Article]
- Harrington MA, Shaw K, Zhong P, Ciaranello RD: Agonist-induced desensitization and loss of high-affinity binding sites of stably expressed human 5-HT1A receptors. J Pharmacol Exp Ther. 1994 Mar;268(3):1098-106. [Article]
- Vasilescu J, Zweitzig DR, Denis NJ, Smith JC, Ethier M, Haines DS, Figeys D: The proteomic reactor facilitates the analysis of affinity-purified proteins by mass spectrometry: application for identifying ubiquitinated proteins in human cells. J Proteome Res. 2007 Jan;6(1):298-305. [Article]
- Nichols DE, Nichols CD: Serotonin receptors. Chem Rev. 2008 May;108(5):1614-41. doi: 10.1021/cr078224o. Epub 2008 May 14. [Article]
- Polter AM, Li X: 5-HT1A receptor-regulated signal transduction pathways in brain. Cell Signal. 2010 Oct;22(10):1406-12. doi: 10.1016/j.cellsig.2010.03.019. Epub 2010 Apr 2. [Article]
- Pytliak M, Vargova V, Mechirova V, Felsoci M: Serotonin receptors - from molecular biology to clinical applications. Physiol Res. 2011;60(1):15-25. Epub 2010 Oct 15. [Article]
- Jiang YC, Wu HM, Cheng KH, Sunny Sun H: Menstrual cycle-dependent febrile episode mediated by sequence-specific repression of poly(ADP-ribose) polymerase-1 on the transcription of the human serotonin receptor 1A gene. Hum Mutat. 2012 Jan;33(1):209-17. doi: 10.1002/humu.21622. Epub 2011 Nov 7. [Article]
- Singh P, Paila YD, Chattopadhyay A: Role of glycosphingolipids in the function of human serotonin(1)A receptors. J Neurochem. 2012 Dec;123(5):716-24. doi: 10.1111/jnc.12008. Epub 2012 Oct 11. [Article]
- Akama KT, Thompson LI, Milner TA, McEwen BS: Post-synaptic density-95 (PSD-95) binding capacity of G-protein-coupled receptor 30 (GPR30), an estrogen receptor that can be identified in hippocampal dendritic spines. J Biol Chem. 2013 Mar 1;288(9):6438-50. doi: 10.1074/jbc.M112.412478. Epub 2013 Jan 8. [Article]
- Nakhai B, Nielsen DA, Linnoila M, Goldman D: Two naturally occurring amino acid substitutions in the human 5-HT1A receptor: glycine 22 to serine 22 and isoleucine 28 to valine 28. Biochem Biophys Res Commun. 1995 May 16;210(2):530-6. [Article]
- Kawanishi Y, Harada S, Tachikawa H, Okubo T, Shiraishi H: Novel mutations in the promoter and coding region of the human 5-HT1A receptor gene and association analysis in schizophrenia. Am J Med Genet. 1998 Sep 7;81(5):434-9. [Article]
Drug Relations
- Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details DB00490 Buspirone approved, investigational yes partial agonist Details DB00216 Eletriptan approved, investigational unknown agonist Details DB00246 Ziprasidone approved yes agonist Details DB01238 Aripiprazole approved, investigational unknown partial agonist Details DB00247 Methysergide approved yes agonist Details DB00363 Clozapine approved unknown antagonist Details DB00589 Lisuride approved, investigational unknown agonist Details DB00656 Trazodone approved, investigational yes antagonistpartial agonist Details DB00866 Alprenolol experimental, withdrawn yes antagonist Details DB00960 Pindolol approved, investigational unknown antagonistinhibitorligand Details DB01224 Quetiapine approved unknown antagonistpartial agonist Details DB04884 Dapoxetine investigational unknown Details DB04888 Bifeprunox investigational unknown Details DB04908 Flibanserin approved, investigational yes agonist Details DB04970 Lesopitron investigational unknown Details DB12061 Pardoprunox investigational unknown Details DB05339 MN-305 investigational unknown Details DB05509 LI-301 investigational unknown Details DB00571 Propranolol approved, investigational unknown other/unknown Details DB06216 Asenapine approved unknown antagonist Details DB06393 Xaliproden investigational unknown Details DB06506 Repinotan investigational unknown Details DB06446 Dotarizine investigational unknown Details DB06454 Sarizotan investigational unknown Details DB06538 Robalzotan investigational unknown Details DB06684 Vilazodone approved unknown agonist Details DB01186 Pergolide approved, investigational, vet_approved, withdrawn unknown agonist Details DB01200 Bromocriptine approved, investigational, withdrawn unknown agonist Details DB00248 Cabergoline approved unknown agonist Details DB00413 Pramipexole approved, investigational unknown agonist Details DB05271 Rotigotine approved unknown agonist Details DB00714 Apomorphine approved, investigational unknown agonist Details DB01267 Paliperidone approved unknown antagonist Details DB01618 Molindone approved unknown antagonist Details DB00321 Amitriptyline approved unknown inhibitorinducer Details DB01142 Doxepin approved, investigational unknown antagonist Details DB01149 Nefazodone approved, withdrawn yes antagonist Details DB00540 Nortriptyline approved unknown antagonist Details DB00726 Trimipramine approved unknown antagonist Details DB01392 Yohimbine approved, investigational, vet_approved unknown partial agonist Details DB00952 Naratriptan approved, investigational yes agonist Details DB00315 Zolmitriptan approved, investigational no agonist Details DB00669 Sumatriptan approved, investigational yes agonist Details DB00477 Chlorpromazine approved, investigational, vet_approved yes antagonist Details DB08807 Bopindolol experimental unknown Details DB00904 Ondansetron approved, withdrawn unknown other/unknown Details DB01616 Alverine approved, investigational yes antagonist Details DB01614 Acepromazine experimental, vet_approved yes antagonist Details DB01621 Pipotiazine approved, investigational yes antagonist Details DB08810 Cinitapride investigational yes agonist Details DB04946 Iloperidone approved unknown antagonist Details DB08815 Lurasidone approved, investigational unknown antagonist Details DB01359 Penbutolol approved, investigational yes antagonist Details DB04829 Lysergic acid diethylamide illicit, investigational, withdrawn unknown Details DB00408 Loxapine approved unknown binder Details DB00458 Imipramine approved unknown activator Details DB00543 Amoxapine approved unknown antagonist Details DB00988 Dopamine approved unknown binder Details DB00696 Ergotamine approved unknown agonist Details DB01151 Desipramine approved, investigational unknown binder Details DB06148 Mianserin approved, investigational unknown blocker Details DB09068 Vortioxetine approved, investigational yes agonist Details DB09128 Brexpiprazole approved, investigational unknown partial agonist Details DB08922 Perospirone experimental yes partial agonist Details DB09167 Dosulepin approved yes antagonist Details DB09061 Cannabidiol approved, investigational unknown agonist Details DB09244 Pirlindole experimental unknown antagonist Details DB06153 Pizotifen approved unknown partial agonist Details DB14010 5-methoxy-N,N-dimethyltryptamine experimental, illicit unknown agonist Details DB14011 Nabiximols investigational unknown Details DB14009 Medical Cannabis experimental, investigational unknown Details DB11755 Tetrahydrocannabivarin investigational yes agonist Details DB04948 Lofexidine approved, investigational no agonist Details DB05562 Naluzotan investigational unknown agonist Details DB09289 Tianeptine investigational unknown inhibitor Details DB14185 Aripiprazole lauroxil approved, investigational yes partial agonist Details DB00422 Methylphenidate approved, investigational unknown Details DB00502 Haloperidol approved unknown Details DB01175 Escitalopram approved unknown inhibitor Details DB15665 SEP-363856 investigational unknown agonist Details DB00734 Risperidone approved, investigational unknown antagonist Details DB00574 Fenfluramine approved, illicit, investigational, withdrawn no agonist Details DB00935 Oxymetazoline approved, investigational unknown agonist Details DB16629 Serdexmethylphenidate approved unknown agonist Details DB00320 Dihydroergotamine approved, investigational unknown agonist Details DB06016 Cariprazine approved, investigational unknown partial agonist Details DB12540 Lecozotan investigational unknown antagonist Details DB00953 Rizatriptan approved unknown agonist Details DB12184 Gepirone investigational yes partial agonist Details DB13025 Tiapride investigational yes antagonist Details DB09304 Setiptiline experimental unknown antagonist Details DB13345 Dihydroergocristine approved, experimental yes antagonist Details DB01049 Ergoloid mesylate approved yes antagonistagonist Details DB11273 Dihydroergocornine approved yes antagonistagonist Details DB12141 Gilteritinib approved, investigational no inhibitor Details DB00715 Paroxetine approved, investigational unknown Details DB01239 Chlorprothixene approved, experimental, investigational, withdrawn yes inhibitor Details DB01221 Ketamine approved, vet_approved unknown antagonist Details DB00334 Olanzapine approved, investigational unknown inhibitor Details DB12540 Lecozotan investigational unknown regulator Details